Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue + Ropivacaine for FICB in Hip Arthroplasty
NCT06520306Enrolling by invitation
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylene blue in postoperative pain (3 arms). Primary endpoints: Visual Analogue Scale at Day 7, Mini-Mental State Examination at Day 7 and 1 more. Started Mar 2024; status: enrolling by invitation.
02
Drugs
methylene blue
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06520306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06520306.